UPDATE: 3SBio Receives Amended 'Go Private' Offer at $16.70/ADS

3SBio Inc. (NASDAQ: SSRX ) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the independent committee of its board of directors (the "Independent Committee") has received a proposal letter (the "Proposal Letter") dated April 22, 2013 from Dr. Jing Lou, the Company's